Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models
about
Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus.Vibrio vulnificus MO6-24/O lipopolysaccharide stimulates superoxide anion, thromboxane B₂, matrix metalloproteinase-9, cytokine and chemokine release by rat brain microglia in vitro.Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infectionGenetic variation in the Vibrio vulnificus group 1 capsular polysaccharide operonDistribution of virulence markers among Vibrio vulnificus isolates of clinical and environmental origin and regional characteristics in Japan.Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2Tumor necrosis factor-α and mortality in patients infected with Vibrio vulnificus.Role of anaerobiosis in capsule production and biofilm formation in Vibrio vulnificus.Identification and characterization of a novel serine protease, VvpS, that contains two functional domains and is essential for autolysis of Vibrio vulnificusHepcidin: the missing link between hemochromatosis and infections.Signature-tagged mutagenesis of Vibrio vulnificus.Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?Vibrio vulnificus: disease and pathogenesis.Inflammatory cytokine response to Vibrio vulnificus elicited by peripheral blood mononuclear cells from chronic alcohol users is associated with biomarkers of cellular oxidative stress.Induction of interleukin-8 production via nuclear factor-kappaB activation in human intestinal epithelial cells infected with Vibrio vulnificus.Expression of Vibrio vulnificus capsular polysaccharide inhibits biofilm formation.Necrotising fasciitis with Vibrio vulnificus: a limb threatening dermatologic complication following exposure to marine life.A case of Vibrio vulnificus infection complicated with fulminant purpura: gene and biotype analysis of the pathogen.RtxA Is a Major Factor Driving Inflammatory T Helper Type 17 Cell Responses and
P2860
Q33552913-C8966E14-3BD5-43E4-B500-CCB022F68308Q33575716-B0CC9DE4-D4D2-4E0E-8DFD-5D9EF8BEC69FQ33715838-4FDD39DC-C1C0-47C3-AA9E-9E533422CDB8Q34509955-4B22B0AA-B169-40A5-97A8-B88123B96D82Q34576224-F1824207-0370-4418-8DE1-EBCF43BEB71DQ34580302-913A23B2-621C-459F-8EC1-1A2A9888B6C0Q34592201-3279286C-D350-4B56-9A01-84E995951742Q34955704-0CABEBDF-BF3B-47F7-908C-596DFA92048FQ35139144-6AC594A8-FA3C-4959-A2E8-898AB74286D8Q35593166-ECD8F0B1-BD68-4AE0-8342-FCC116654D28Q35924128-BECB7904-A9D1-466C-A2A2-B47EF1E65433Q36421502-290F8996-6B86-4A9E-B256-EFA6F23208FFQ37405123-55E0008C-2033-402C-B16F-1F884501D2C0Q39776731-662AF0F7-D984-428A-9DA5-7CF2E73C7D2BQ40398658-81EDF068-7C69-4151-82C7-24311243199DQ40469158-D3628B97-26B2-45A7-8050-CD8EC0DF9055Q41883681-1DFDD56F-605A-45C6-A45F-947F2611156BQ42273849-5A3D1E0D-D7B9-45FC-A538-19BF66C2C6EDQ57072716-45FE3C6E-89E1-4F1B-BA97-4542BBC931DD
P2860
Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Release of tumor necrosis fact ...... in in vivo and in vitro models
@ast
Release of tumor necrosis fact ...... in in vivo and in vitro models
@en
type
label
Release of tumor necrosis fact ...... in in vivo and in vitro models
@ast
Release of tumor necrosis fact ...... in in vivo and in vitro models
@en
prefLabel
Release of tumor necrosis fact ...... in in vivo and in vitro models
@ast
Release of tumor necrosis fact ...... in in vivo and in vitro models
@en
P2093
P2860
P1476
Release of tumor necrosis fact ...... in in vivo and in vitro models
@en
P2093
Morris JG Jr
Wasserman SS
P2860
P304
P407
P577
1997-09-01T00:00:00Z